Kappelmann Richard K MD is categorized under Internal Medicine Practitioners in Lewiston, ME and active since 1989.
Kappelmann Richard K MD was established in 1989, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Richard Kappelmann at the company’s single location by writing to 100 Campus Avenue Apartment 203, Lewiston, Maine ME 04240 or by phoning (207) 777-4100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Kappelmann Richard K MD |
Contact Person: | Richard Kappelmann |
Address: | 100 Campus Avenue Apartment 203, Lewiston, Maine 04240 |
Phone Number: | (207) 777-4100 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1989 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Kappelmann Richard K MD was started in 1989 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Kappelmann for inquiries that concern Kappelmann Richard K MD by calling the company number (207) 777-4100, as your correspondence is most welcome. Additionally, the physical location of the single location of Kappelmann Richard K MD can be found at the coordinates 44.102399,-70.200052 as well as the street address 100 Campus Avenue Apartment 203 in Lewiston, Maine 04240.
For its online presence, you may visit Kappelmann Richard K MD’s website at and engage with its social media outlets through on Twitter and on Facebook.